Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Selvita
Selvita
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
From batch to continuous chemistry to continuous processing
The main challenge in many flow reactors lies in achieving a smooth and continuous flow within microchannels. Dec Group focuses on effectively transporting solid materials and...
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Recruitment
Selvita appoints Dr Steffen Heeger as Chief Medical Officer
Research & Development
Selvita promotes Edyta Jaworska to its management board
Research & Development
Epidarex Capital creates Nodthera Limited
A pioneering new company based on Selvita research and utilising novel immunological approaches to disease
Design & Build
Selvita opens new research site in Poznan, Poland
Will initially employ around 50 chemist and biologists
Research & Development
Merck and Selvita enter new drug discovery collaboration
With the aim of discovering small molecule lead candidates for multiple oncology indications
Finance
Selvita launches new company
Ardigen will focus on bioinformatics and personalised medicine
Research & Development
Selvita establishes UK subsidiary in Cambridge
To be closer to business partners located in the UK
Subscribe now